Stay updated on Pro-Netupitant Palonosetron IV Safety Clinical Trial
Sign up to get notified when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.

Latest updates to the Pro-Netupitant Palonosetron IV Safety Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedThe page revision shows a shift from v3.4.1 to v3.4.2, a minor maintenance update with no changes to study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check18 days agoChange DetectedThe page now displays Revision: v3.4.1 instead of v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check32 days agoChange DetectedUI changes add glossary visibility controls (Show glossary / Hide glossary) and display a new revision label (Revision: v3.4.0) along with 'Last Update Submitted that Met QC Criteria'. The previous labels 'Last Update Submitted that met QC Criteria' and 'No FEAR Act data' were removed.SummaryDifference0.2%

- Check39 days agoChange DetectedPage revision updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check68 days agoChange DetectedAdded a consolidated Locations section listing multiple site locations (California, Colorado, Florida, Illinois, Indiana, Louisiana, New York, Ohio, Tennessee, Andalusia) and removed the prior state-specific Location blocks; the HHS Vulnerability Disclosure link was deleted and the revision updated to v3.3.3.SummaryDifference0.7%

- Check90 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study; also updated the page revision to v3.3.2. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Pro-Netupitant Palonosetron IV Safety Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pro-Netupitant Palonosetron IV Safety Clinical Trial page.